Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 11/2007

01-11-2007 | Case Report

Successful Endoscopic Management of Bronchobiliary Fistula Due to Radiofrequency Ablation

Authors: Thomas Tran, Howard Hampel, Waqar A. Qureshi, Yasser Shaib

Published in: Digestive Diseases and Sciences | Issue 11/2007

Login to get access

Excerpt

Bronchobiliary fistula is an extremely rare condition defined as a passageway between the biliary and the bronchial tracts. The pathognomonic sign is the presence of bile in the sputum (bilioptysis). The most common causes are trauma, bile duct obstruction, and liver infections [1]. Treatment is traditionally surgical repair. However, endoscopic intervention has been increasingly used, with variable success. This case is the first report of bronchobiliary fistula as a complication of radiofrequency ablation (RFA) that was successfully managed endoscopically. …
Literature
1.
Gugenheim J, Ciardullo M, Traynor O, Bismuth H (1988) Bronchobiliary fistulas in adults. Ann Surg 207:90–94PubMedCrossRef
2.
Peacock TB (1850) Case in which hydatids were expectorated and one of suppuration of a hydatid cyst of the liver communicating with the lungs. Edinburgh Med Surg J 74:33–46
3.
Kim Y-S, Rhim H, Sung JH, Kim SK, Kim Y, Koh BH, Cho OK, Kwon S-J (2005) Bronchobiliary fistula after radiofrequency thermal ablation of hepatic tumor. J Vasc Interv Radiol 16:407–410PubMed
4.
Velchik MG, Roth GM, Wegener W, Alavi A (1991) Bronchobiliary fistula detected by cholescintigraphy. J Nucl Med 32:136–138PubMed
5.
Flemma RJ, Amlyan WG, Durham NG (1965) Tuberculous bronchobiliary fistula. J Thorac Cardiovasc Surg 49:198–201PubMed
6.
Watkins L, Laufer I, Evans G, Mullens J (1975) Biliary bronchial fistula demonstrated by endoscopic retrograde cholangiography. Can Med Assoc J 113:868–874PubMed
7.
Ragozzino Q, De Rosa R, Galdiero R, Maio A, Manes G (2005) Bronchobiliary fistula evaluated with magnetic resonance imaging. Acta Radiol 46:452–454PubMedCrossRef
8.
9.
Chua HK, Allen MS, Deschamps C, Miller D, Pairolero PC (2000) Bronchobiliary fistula: principles of management. Ann Thorac Surg 70:1392–1394PubMedCrossRef
10.
Brem H, Gibbons GD, Cobb G, Edgin RA, Ellison EC, Carey LC (1990) The use of endoscopy to treat bronchobiliary fistula caused by choledocholithiasis. Gastroenterology 98:490–492PubMed
11.
Khandelwal M, Inverso N, Conter R, Campbell D (1996) Endoscopic management of a bronchobiliary fistula. J Clin Gastroenterol 23:125–127PubMedCrossRef
12.
Singh B, Moodley J, Sheik-Gafoor MH, Dhooma N, Reddi A (2002) Conservative management of thoracobiliary fistula. Ann Thorac Surg 73:1088–1091PubMedCrossRef
13.
D’Altorio RA, McAllister JD, Sestric GB, Cichon PJ (1992) Hepatopulmonary fistula: treatment with biliary metallic endoprosthesis. Am J Gastroenterol 87:784–786PubMed
14.
Singh B, Moodley J (2004) Octreotide in bronchobiliary fistula management. Ann Thorac Surg 78:1513CrossRef
15.
Ong M, Moozar K, Cohen LB (2004) Octreotide in bronchobiliary fistula management. Ann Thorac Surg 78:1512–1513PubMedCrossRef
Metadata
Title
Successful Endoscopic Management of Bronchobiliary Fistula Due to Radiofrequency Ablation
Authors
Thomas Tran
Howard Hampel
Waqar A. Qureshi
Yasser Shaib
Publication date
01-11-2007
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 11/2007
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9331-x

Other articles of this Issue 11/2007

Digestive Diseases and Sciences 11/2007 Go to the issue

Original Paper

Fulminant Hepatic Failure in an African Setting: Etiology, Clinical Course, and Predictors of Mortality

Original Article

Pancreatic Pseudocysts and a Cyst-Duodenal Fistula Complicating Severe Necrotizing Pancreatitis from Pancreas Divisum

Original Paper

Sequential Observations Show Upregulation of TGF-β1 at the Early Phase of Chronic Small Bowel Rejection in Rats

Review Article

Epidemiology, Pathogenesis, and Management of Clostridium difficile Infection

Basic Research

Ischemic Preconditioning and Intermittent Ischemia Preserve Bile Flow in a Rat Model of Ischemia/Reperfusion Injury

Original Paper

Causes of Death in Patients with Unresectable Hepatocellular Carcinoma
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits